• Explore /
  • Poster
  • / Is health-related quality of life (HRQoL) reporting keeping pace with new drug approvals in hematology and oncology: A five-year analysis of 245 drug approvals.

Is health-related quality of life (HRQoL) reporting keeping pace with new drug approvals in hematology and oncology: A five-year analysis of 245 drug approvals.

Abstract Poster

Authors

Medhavi Gupta

Medhavi Gupta

Women & Infants Hospital, Brown Alpert School of Medicine, Providence, RI

Medhavi Gupta , Othman Salim Akhtar , Bhavyaa Bahl , Angel Mier-Hicks , Kristopher Attwood , Kayla Catalfamo , Bishal Gyawali , Pallawi Torka

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Health Services Research and Quality Improvement

Track

Quality Care/Health Services Research

Sub Track

Quality Improvement

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 6519)

DOI

10.1200/JCO.2022.40.16_suppl.6519

Abstract #

6519

Poster Bd #

302

Abstract Disclosures

Similar Posters

First Author: Thilo Westhofen

First Author: Celine Yeh

First Author: Michal Sternschuss

First Author: Jin-Ji Yang